Ask a doctor about a prescription for CINACALCET MYLAN 90 mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Cinacalcet Mylan 30 mg film-coated tablets EFG
Cinacalcet Mylan 60 mg film-coated tablets EFG
Cinacalcet Mylan 90 mg film-coated tablets EFG
cinacalcet
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Cinacalcet Mylan contains the active substance cinacalcet, which controls the levels of parathyroid hormone (PTH), calcium, and phosphorus in your body. It is used to treat disorders of the parathyroid glands. The parathyroid glands are four small glands located in the neck, near the thyroid gland, which produce parathyroid hormone (PTH).
Cinacalcet Mylan is used:
primary hyperparathyroidism when the parathyroid gland cannot be removed.
In primary and secondary hyperparathyroidism, the parathyroid glands produce too much PTH.
The term "primary" means that the hyperparathyroidism is not caused by any other disease, and "secondary" means that the hyperparathyroidism is caused by another disease, such as kidney disease. Both primary and secondary hyperparathyroidism can cause calcium to be lost from the bones, which can lead to bone pain and fractures, problems with blood vessels and heart vessels, kidney stones, mental illness, and coma.
Do not take Cinacalcet Mylanif you are allergic to cinacalcet or any of the other ingredients of this medicine (listed in section 6).
Do not take Cinacalcet Mylanif you have low levels of calcium in your blood. Your doctor will monitor your blood calcium levels.
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before you start taking Cinacalcet Mylan.
Before you start taking Cinacalcet Mylan, tell your doctor if you have or have had:
Cinacalcet Mylan lowers calcium levels. Potentially life-threatening and fatal events associated with low calcium levels (hypocalcemia) have been reported in patients treated with cinacalcet.
Tell your doctor if you have any of the following symptoms that would indicate low calcium levels: muscle spasms, muscle twitching, or cramps, or numbness or tingling in the fingers, or around the mouth, or seizures, confusion, or loss of consciousness, while taking Cinacalcet Mylan.
Low calcium levels can affect your heart rhythm. Tell your doctor if you experience unusually strong or fast heartbeats, if you have problems with your heart rhythm, or if you are taking medicines that cause heart rhythm problems, while taking Cinacalcet Mylan.
For more information, see section 4.
During treatment with Cinacalcet Mylan, tell your doctor:
Children and adolescents
Children under 18 years should not take Cinacalcet Mylan.
If you are being treated for secondary hyperparathyroidism, your doctor should monitor your calcium levels before starting treatment with Cinacalcet Mylan and during treatment with Cinacalcet Mylan. You should tell your doctor if you have any of the symptoms related to low calcium levels described above.
It is important that you take your dose of Cinacalcet Mylan exactly as your doctor has told you.
Taking Cinacalcet Mylan with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, in particular etelcalcetide or any other medicine that lowers calcium levels in your blood.
Do not take Cinacalcet Mylan with etelcalcetide.
Tell your doctor if you are taking the following medicines.
Medicines like the following may change the effect of Cinacalcet Mylan:
Cinacalcet Mylan may change the effect of medicines like the following:
Taking Cinacalcet Mylan with food and drinks
Cinacalcet Mylan should be taken with food or shortly after eating.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Cinacalcet has not been studied in pregnant women. In case of pregnancy, your doctor may decide to change your treatment, as cinacalcet may be harmful to the unborn baby.
It is not known whether cinacalcet passes into breast milk. Your doctor will tell you if you should stop breastfeeding or stop Cinacalcet Mylan treatment.
Driving and using machines
In patients taking Cinacalcet Mylan, cases of dizziness and seizures have been reported. If you experience these effects, do not drive or use machines.
Take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Your doctor will tell you how much Cinacalcet Mylan to take.
Cinacalcet Mylan should be taken by mouth, with food or shortly after eating. The tablets should be swallowed whole and not chewed, crushed, or broken.
Your doctor will regularly perform blood tests during treatment to monitor your progress and, if necessary, adjust the dose you receive.
If the treatment is for secondary hyperparathyroidism
The usual starting dose of Cinacalcet Mylan is 30 mg (one tablet) once a day.
If the treatment is for parathyroid cancer or primary hyperparathyroidism
The usual starting dose of Cinacalcet Mylan is 30 mg (one tablet) twice a day.
If you take more Cinacalcet Mylan than you should
If you have taken more Cinacalcet Mylan than you should, contact your doctor immediately. Possible signs of overdose include numbness or tingling around the mouth, muscle pain or cramps, and seizures.
If you forget to take Cinacalcet Mylan
Do not take a double dose to make up for forgotten doses.
If you have forgotten to take a dose of Cinacalcet Mylan, take the next dose at the usual time.
If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.
Like all medicines, Cinacalcet Mylan can cause side effects, although not everybody gets them.
Tell your doctor immediately:
Other possible side effects:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Not known: frequency cannot be estimated from the available data
In a small number of patients with heart failure, their disease and/or low blood pressure (hypotension) worsened after taking Cinacalcet Mylan.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Cinacalcet Mylan contains
The active substance is cinacalcet. Each film-coated tablet contains 30 mg, 60 mg, or 90 mg of cinacalcet (as hydrochloride).
The other ingredients are microcrystalline cellulose, anhydrous colloidal silica, povidone, crospovidone, magnesium stearate.
The film coating contains hypromellose, titanium dioxide (E171), triacetin, indigo carmine (E132), and yellow iron oxide (E172).
Appearance and packaging
Cinacalcet Mylan is a film-coated tablet, light green in color. They are oval, biconvex, with beveled edges, and marked with an "M" on one side and "CI30", "CI60", or "CI90" on the other.
Cinacalcet Mylan is available in blister packs of 28 film-coated tablets of 30 mg, 60 mg, or 90 mg and unit dose blister packs of 28 x 1 and 30 x 1 film-coated tablets.
Cinacalcet Mylan is also available in bottles of 30 mg film-coated tablets. Each bottle contains 100 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder
Mylan S.A.S.
117 Allee des Parcs
69 800 Saint Priest
France
Manufacturers
Mylan Hungary Kft
H-2900 Komárom, Mylan utca 1
Hungary
McDermott Laboratories Limited trading as Gerard Laboratories
35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13
Ireland
Mylan B.V.
Dieselweg 25, 3752 LB Bunschoten
Netherlands
You can request more information about this medicine from the local representative of the marketing authorisation holder.
België/Belgique/Belgien Mylan bvba/sprl Tél/Tel: + 32 (0)2 658 61 00 | Lietuva BGP Products UAB Tel: + 370 5 205 1288 |
България ?????? ???? ???: +359 2 44 55 400 | Luxembourg/Luxemburg Mylan bvba/sprl Tel: + 32 (0)2 658 61 00 (Belgique/Belgien) |
Ceská republika Mylan Pharmaceuticals s.r.o. Tel: + 420 222 004 400 | Magyarország Mylan EPD Kft Tel: + 36 1 465 2100 |
Danmark Mylan AB Tlf: + 46 855 522 750 (Sverige) | Malta V.J. Salomone Pharma Ltd Tel: + 356 21 22 01 74 |
Deutschland Mylan dura GmbH Tel: + 49-(0) 6172 888 01 | Nederland Mylan BV Tel: + 31 (0)20 426 3300 |
Eesti BGP Products Switzerland GmbH Eesti filiaal Tel: + 372 6363 052 | Norge Mylan AB Tel: + 46 855 522 750 (Sverige) |
Ελλάδα Generics Pharma Hellas ΕΠΕ Τηλ: +30 210 993 6410 | Österreich Arcana Arzneimittel GmbH Tel: + 43 1 416 2418 |
España Mylan Pharmaceuticals S.L. Tel: + 34 900 102 712 | Polska Mylan Healthcare Sp. z.o.o. Tel: + 48 22 546 64 00 |
France Mylan S.A.S Tel: + 33 4 37 25 75 00 | Portugal Mylan, Lda. Tel: + 351 21 412 72 56 |
Hrvatska Mylan Hrvatska d.o.o. Tel: +385 1 23 50 599 | România BGP Products SRL Tel: +40 372 579 000 |
Ireland Mylan Ireland Tel: +353 (0) 87 1694982 | Slovenija GSP Proizvodi d.o.o. Tel: + 386 1 236 31 85 |
Ísland Mylan AB Tel: + 46 855 522 750 (Svíþjóð) | Slovenská republika Mylan s.r.o. Tel: + 421 2 32 199 100 |
Italia Mylan S.p.A Tel: + 39 02 612 46921 | Suomi/Finland Mylan OY Puh/Tel: + 358 20 720 9555 |
Κύπρος Pharmaceutical Trading Co. Ltd. Τηλ: + 357 99403969 | Sverige Mylan AB Tel: + 46 855 522 750 |
Latvija BGP Products SIA Tel: + 371 676 055 80 | United Kingdom Generics [UK] Ltd Tel: + 44 1707 853000 |
Date of last revision of this leaflet:
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for CINACALCET MYLAN 90 mg FILM-COATED TABLETS – subject to medical assessment and local rules.